The Procoagulant Effect of COVID-19 on the Thrombotic Risk of Patients with Hip Fractures Due to Enhanced Clot Strength and Fibrinolysis Shutdown.
Andreas G TsantesDimitrios V PapadopoulosIoannis G TrikoupisStavros GoumenosDaniele PiovaniKonstantina A TsanteAndreas F MavrogenisAristeidis G VaiopoulosPanagiotis KoulouvarisGeorgios K NikolopoulosPanayiotis J PapagelopoulosStefanos BonovasArgirios E TsantesPublished in: Journal of clinical medicine (2021)
The higher thrombotic risk in COVID-19 patients with hip fractures is characterized by increased clot strength and fibrinolysis shutdown, as shown by ROTEM findings. Further prospective studies are warranted to evaluate the need for modification of thromboprophylaxis to balance the hemostatic derangements of COVID-19 patients with hip fractures.